Viropil Dolutegravil Lamivudine & Tenofovir disoproxil fumarate tabletd ip

About Viropil Dolutegravil Lamivudine & Tenofovir disoproxil fumarate tabletd ip

Composition: Dolutegravir, Lamivudine & Tenofovir Disoproxil Fumarate Tablets IP

Viropil Tablet is a fixed-dose combination antiretroviral medicine used in the treatment of HIV-1 infection. It works by inhibiting viral replication, helping to reduce the viral load and improve immune function when taken as part of a complete antiretroviral therapy (ART) regimen.

This combination is recommended due to its high efficacy, good tolerability, and once-daily dosing convenience, making it suitable for long-term HIV management.

• Effective in controlling HIV-1 infection

• Helps reduce viral load and increase CD4 count

• Once-daily oral administration

• Well-tolerated combination therapy

• Recommended in first-line ART regimens

• Dolutegravir IP

• Lamivudine IP

• Tenofovir Disoproxil Fumarate IP
  (Dosage as per IP standards)

• Treatment of HIV-1 infection in adults and adolescents

• Used as part of combination antiretroviral therapy

• To be taken as directed by a healthcare professional

• Usually administered once daily, with or without food

• Store in a cool, dry place

• Protect from light and moisture

• Keep out of reach of children

• Prescription medicine; use under medical supervision only

• Not a cure for HIV but helps in long-term management

• Regular monitoring is advised during treatment

• Available in strip/bottle packaging

• Packaging may vary as per requirement